Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 5 Results

  1. 1

    Guidelines for integrating sexual and reproductive health into the HIV / AIDS component of country coordinated proposals to be submitted to the Global Fund to Fight AIDS, Tuberculosis and Malaria: Round 8 and beyond. Updated 18 February 2008.

    Doupe A

    [London, England], Interact Worldwide, 2008 Feb 18. 36 p.

    The Global Fund to Fight AIDS, Tuberculosis and Malaria, a unique multilateral partnership that has proven itself to be a successful mechanism for fighting these diseases, is an important funding vehicle for innovative responses to the three diseases, including SRH-HIV / AIDS integration. In preparation for upcoming and future Global Fund funding rounds, Guidelines for Integrating Sexual and Reproductive Health into the HIV / AIDS Component of Country Coordinated Proposals to be submitted to the Global Fund to Fight AIDS, Tuberculosis and Malaria is designed to support Country Coordinated Mechanisms (CCMs) to develop Country Coordinated Proposals for the Global Fund that integrate sexual and reproductive health into the HIV / AIDS component. (Excerpt)
    Add to my documents.
  2. 2
    Peer Reviewed

    Obstetric fistula: Guiding principles for clinical management and programme development, a new WHO guideline.

    de Bernis L

    International Journal of Gynecology and Obstetrics. 2007 Nov; 99 Suppl 1:S117-S121.

    It is estimated that more than 2 million women are living with obstetric fistulas (OFs) worldwide, particularly in Africa and Asia, and yet this severe morbidity remains hidden. As a contribution to the global Campaign to End Fistula, the World Health Organization (WHO) published Obstetric fistula: Guiding principles for clinical management and programme development, a manual intended as a practical working document. Its 3 main objectives are to draw attention to the urgency of the OF issue and serve as an advocacy document for prompt action; provide policy makers and health professionals with brief, factual information and principles that will guide them at the national and regional levels as they develop strategies and programs to prevent and treat OFs; and assist health care professionals as they acquire better skills and develop more effective services to care for women treated for fistula repair. (author's)
    Add to my documents.
  3. 3

    Medical eligibility criteria for contraceptive use. 3rd ed.

    World Health Organization [WHO]

    Geneva, Switzerland, WHO, Department of Reproductive Health and Research, 2004. [197] p.

    This document is one important step in a process for improving access to quality of care in family planning by reviewing the medical eligibility criteria for selecting methods of contraception. It updates the second edition of Improving access to quality care in family planning: medical eligibility criteria for contraceptive use, published in 2000, and summarizes the main recommendations of an expert Working Group meeting held at the World Health Organization, Geneva, 21-24 October 2003. (Please see Annex 2 for the list of participants.) The Working Group brought together 36 participants from 18 countries, including representatives of many agencies and organizations. The document provides recommendations for appropriate medical eligibility criteria based on the latest clinical and epidemiological data and is intended to be used by policy-makers, family planning programme managers and the scientific community. It aims to provide guidance to national family planning/reproductive health programmes in the preparation of guidelines for service delivery of contraceptives. It should not be seen or used as the actual guidelines but rather as a reference. The document covers the following family planning methods: low-dose combined oral contraceptives (COCs), combined injectable contraceptives (CICs), combined patch (P), combined vaginal ring (R), progestogen-only pills (POPs), depot medroxyprogesterone acetate (DMPA), norethisterone enantate (NET-EN), levonorgestrel (LNG) and etonogestrel (ETG) implants, emergency contraceptive pills (ECPs), copper intrauterine devices (Cu- IUDs), levonorgestrel-releasing IUDs (LNG-IUDs), copper-IUD for emergency contraception (E-IUD), barrier methods (BARR), fertility awareness-based methods (FAB), lactational amenorrhoea method (LAM), coitus interruptus (CI), and female and male sterilization (STER). (excerpt)
    Add to my documents.
  4. 4

    HIV prevention in maternal health services: programming guide.

    Perchal P; Farrell B; Koumpounis A; Galvão L; Mielke E

    New York, New York, United Nations Population Fund [UNFPA], 2004. [148] p.

    While this guide primarily addresses HIV prevention, it also makes the link to other STI’s, since these can increase a pregnant woman’s succeptibility to HIV infection and since both HIV/AIDS and other STI’s can be transmitted to the foetus or newborn child. While preventing HIV infection in pregnant women is a critical element in preventing HIV transmission to the child (vertical transmission), this guide does not attempt to duplicate the many training aides and programme guides that already address prevention of vertical transmission. Prevention of mother-to-child transmission (PMTCT) is more than the provision of antiretroviral drugs to prevent transmission of HIV from an HIV-positive woman to her infant. A comprehensive programme to prevent HIV transmission to pregnant women, mothers, and their children, which has been endorsed by the UN system, includes four elements known as PMTCT, defined as: 1. Prevention of HIV, especially among young people and pregnant women. 2. Prevention of unintended pregnancies among HIV-infected women. 3. Prevention of HIV transmission from HIV-infected women to their infants. 4. Provision of treatment, care, and support to HIV-infected women and their families. This guide focuses primarily on the first of the four elements. (excerpt)
    Add to my documents.
  5. 5

    WHO antenatal care randomized trial: Manual for the implementation of the new model. [Estudio clínico aleatorizado de control prenatal de la OMS: Manual para la puesta en práctica del nuevo modelo]

    Villar J; Bergsjo P

    Geneva, Switzerland, World Health Organization [WHO], 2002. 33 p.

    This manual describes the basic component of the new WHO antenatal care model. It provides detailed instructions on how to conduct the four-visit schedule of the basic component of the new WHO model. It includes a classifying form for easy assessment of a woman’s eligibility for the basic component, and provides a checklist of activities that are to be performed throughout the four-visit schedule. It is important to emphasize that the basic component of the new WHO antenatal care model is intended only for the management of pregnant women who do not have evidence of pregnancy-related complications, medical conditions or major health-related risk factors. For the management of women who have such conditions, health providers are advised to follow the recommended established procedures of their clinic or hospital. The clinics or hospitals that do not have established procedures for women with such conditions, or that wish to update the ones they currently have, can use The WHO Reproductive Health Library to identify evidence-based interventions. (author's)
    Add to my documents.